Perisynaptic and extrasynaptic δ subunit-containing GABAA receptors (δ-GABAARs) mediate tonic conductances in many principal cells and interneurons (INs) of the central nervous system. δ-GABAARs comprise α4 subunits on principal cells of the neocortex and hippocampus, whereas they usually contain α1 on various INs. δ-GABAARs are highly plastic and exhibit a unique pharmacology, being insensitive to benzodiazepines, but sensitive to low concentrations of neurosteroids (NS). The neuroactive forms of several steroid hormones, NS act on δ-GABAARs as potent positive allosteric modulators leading to changes in neuronal excitability and network synchrony. In fact, δ-GABAARs on INs have been shown to control the dynamics of γ oscillations.
During times of altered NS production, including stress, puberty, ovarian cycle and pregnancy, δ-GABAAR expression varies in different neurons regardless of the α subunits they contain. This plasticity has direct consequences for network functioning. In particular, plasticity of these receptors in pregnancy and the postpartum period affects CA3 γ oscillation frequencies (recorded in vitro), and during the ovarian cycle they underlie fluctuations in the amplitude of CA1 γ oscillations (recorded in vivo).
Most δ-GABAAR-expressing INs in CA3 stratum pyramidale (SP) are parvalbumin (PV)+INs, whose fundamental role in γ oscillation generation and control has been extensively investigated. In this study we reduced or deleted δ-subunits in PV+INs, with the use of a PV/Cre-Gabrd/floxed genetic system. By means of immunohistochemistry we show that PV expression in PV-Gabrd−/− and PV-Gabrd+/− mice remains unaltered. Additionally, we confirm the absence of δ-GABAARs specifically from PV+INs. We find that in both PV-Gabrd−/− and PV-Gabrd+/− mice, CA3 γ oscillation frequencies measured in vitro were increased compared to Cre−/− controls. The increased frequencies could be lowered to control levels in PV-Gabrd+/− by the NS allopregnanolone (3α,5α-tetrahydroprogesterone, ALLO, 100 nM) but not by the synthetic δ-GABAAR positive allosteric modulator 4-Chloro-N-[2-(2-thienyl)imidazo[1,2-a]pyridin-3-yl] benzamide (DS-2, 10 µM). This is consistent with the idea that DS-2, in contrast to ALLO, selectively targets α4/δ-GABAARs but not the α1/δ-GABAARs found on INs. Therefore, development of drugs selective for IN-specific α1/δ-GABAARs may be useful in neurological and psychiatric conditions correlated with altered PV+IN function and aberrant γ oscillations.